A Simplified Expedited Screening of Haemoglobinopathy and Pre-Diabetes in Whole Blood Using MALDI MS

  • Clinical MALDI-TOF-MS requires not only accurate mass determination but also quantitative measurement e.g. as used in the direct identification of haemoglobinopathy and diabetes from blood prick sample. This has been demonstrated by us and Dr Marvin Vestal's group (1,2,3).
  • Two aspects are known to affect the reliability of quantification result in MALDI: (i) number of shots averaged and (ii) optimal dilution of the sample.
  • Here, we examine the effect of the acquisition strategy (number of laser shots, sampling method) for achieving optimised but rapid data for qualitative and quantitative blood globin analysis from pin prick blood.

*Not available in the U.S.

Content Type:
Paper
Document Number:
PO-CON1761E
Product Type:
Mass Spectrometry, Life Science Lab Instruments, MALDI-TOF Mass Spectrometry
Keywords:
Clinical research, Forensics, Healthcare, Clinical research, MALDI-8020
Language:
English
File Name:
ego317086.pdf
File Size:
489kb

View Article

For Research Use Only. Not for use in diagnostic procedures.

This page may contain references to products that are not available in your country. Please contact us to check the availability of these products in your country.

Top of This Page

Please select your country or region.

Transferring to the local website of your country or region.

Transfer to
https://www.ssi.shimadzu.com/